Provided by Tiger Trade Technology Pte. Ltd.

Quantum Biopharma Ltd.

3.60
-0.2200-5.76%
Pre-market: 3.660.0600+1.67%04:00 EDT
Volume:114.06K
Turnover:413.48K
Market Cap:29.12M
PE:-0.67
High:3.80
Open:3.72
Low:3.53
Close:3.82
52wk High:19.30
52wk Low:2.07
Shares:8.09M
Float Shares:7.65M
Volume Ratio:0.34
T/O Rate:1.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.3537
EPS(LYR):-7.9660
ROE:-621.46%
ROA:-51.84%
PB:3.66
PE(LYR):-0.45

Loading ...

Quantum BioPharma (NASDAQ: QNTM) Receives FDA Green Light to Move Lucid-MS into Phase 2 Testing

TIPRANKS
·
Sep 25

Quantum BioPharma Licensee Unbuzzd Names Michael Zapolin CEO

Reuters
·
Sep 24

Quantum Biopharma Licensee Unbuzzd Wellness to Advance Clinically Validated Alcohol Metabolism Accelerant After Appointing Zappy as CEO

GlobeNewswire
·
Sep 24

Quantum BioPharma (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments

TIPRANKS
·
Sep 24

Inside Quantum World Congress: Where FBI Agents, Big Tech, and Stock Hype Converge

Dow Jones
·
Sep 24

Quantum BioPharma Board Authorizes Class a Multiple-Voting Share Offering to Lift Control Stake to 75.27%

Reuters
·
Sep 18

Quantum BioPharma Plans Debt Conversion at Conversion Price of CAD 4 Per Share

Reuters
·
Sep 18

Quantum BioPharma Grants 7,692 Stock Options to Director Zapolin at C$ 6.6 Per Share

Reuters
·
Sep 18

Quantum BioPharma (NASDAQ: QNTM) Announces that Rodman & Renshaw Initiates Coverage with Buy Rating, $8 Price Target

TIPRANKS
·
Sep 18

Rodman & Renshaw Initiates Quantum BioPharma Coverage with Buy Rating, US$ 8 Target

Reuters
·
Sep 17

Quantum BioPharma (NASDAQ: QNTM) to Present at 3rd Annual ArcStone-Kingswood Growth Summit

TIPRANKS
·
Sep 16

Quantum BioPharma to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto

GlobeNewswire
·
Sep 15

Stray Alert on Quantum BioPharma Withdrawn

Reuters
·
Sep 14

Networknewsaudio Announces Audio Press Release (Apr) Discussing FDA Clearance for Trial of First-in-Class Treatment Creating ‘Rare Moment’ in MS Research

THOMSON REUTERS
·
Sep 14

Quantum BioPharma Wins FDA Clearance for Lucid-MS Phase 2 Trial

Reuters
·
Sep 11

Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials

GlobeNewswire
·
Sep 11

Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment

GlobeNewswire
·
Sep 09

Quantum Biopharma Amends Form 6-K to Add Exhibit to F-3 Registration Statement

Reuters
·
Sep 09

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Draws ‘Buy’ Rating on Lucid-MS Potential

TIPRANKS
·
Sep 01

Quantum Biopharma Provides Corporate Update

GlobeNewswire
·
Aug 22